S

Sobi

Pharmaceutical Manufacturing1001-5000 employeesPublic Company

Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. We are dedicated to capturing the scientific opportunities of our time. With our early roots in Sweden, we started as pioneers in haemophilia. Today we are an innovative leader within rare diseases with a global reach. Together we are bringing brilliant ideas to life. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK 26 billion. Sobi’s share (STO:SOBI) is listed on Nasdaq Stockholm. More about Sobi at  sobi.com and LinkedIn.

Specialties

orphan drugshereditary metabolic disordershaemophiliabiopharmaceuticalspatient accessrare diseaseshaematologyhematologyimmunologyautoimmune

Funding

Public
US$ 274.9Mlast round, Jun 20242 total rounds

89 open remote positions

United States

Full-time

Posted 3 days ago

AWS

United States

Full-time

Posted 4 days ago

AWS

Czech Republic

Full-time

Posted 5 days ago

Poland

Full-time

Posted 8 days ago

Slovakia

Full-time

Posted 8 days ago

Croatia

Full-time

Posted 8 days ago

Hungary

Full-time

Posted 8 days ago

Slovenia

Full-time

Posted 8 days ago

Romania

Full-time

Posted 8 days ago

Bulgaria

Full-time

Posted 8 days ago

Czech Republic

Full-time

Posted 11 days ago

Poland

Full-time

Posted 11 days ago

Poland

Full-time

Posted 11 days ago

GCP

Croatia

Full-time

Posted 11 days ago

Czech Republic

Full-time

Posted 12 days ago

Germany

Full-time

Posted 16 days ago

Germany

Full-time

Posted 17 days ago

Netherlands

Full-time

Posted 17 days ago

Germany

Full-time

Posted 17 days ago